To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

Publications

  • News for the week of October 8, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Reminder to complete our survey on the first three initiatives to expand scope of practices for pharmacists
    • Federal campaign resources from our pharmacy partners

    • Paid Consultations - Opportunities and Timesavers
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Injections and Immunizations Program

    • Ask the Customer Experience and Administration Team

    • Surviving a critical illness
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: Multiple Oncology Products (Fludarabine, Hydroxyurea, Raltitrexed, Tamoxifen)
    • Drug Shortage / Supply Health System Alert: Pfizer Canada - Oxytocin 1ml ampoule

    • DDD Notice No. 19147 posted October 4, 2019 Prescription Forgery Alert
    • DDD Notice No. 19148 posted October 4, 2019 Prescription Forgery Alert

  • News for the week of October 1, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Complete our survey on the first three initiatives to expand scope of practices for pharmacists

    • Opioid Addictions and Substitution Therapy FREE Online Modules
    • The Master Plan for Diabetes Continuing Education Program
    • Identifying Drug Interactions

    • Ask the Practice Support Network

    • OPA Secure Health Plan: All-in-one health care package
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: Fresenius Kabi - Oxytocin 1ml vial

    • DDD Notice No. 19141 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19140 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19139 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19138 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19137 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19136 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19135 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19134 posted September 30, 2019 Notice from the Executive Office

    • Ranitidine - Information Update
    • Health Product InfoWatch - September 2019

  • News for the week of September 24, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Fluzone® High-Dose not made available in pharmacy this flu season
    • September 25, 2019 is World Pharmacists Day!

    • Take-Home Naloxone Program at Community Pharmacies
    • Opioid Addiction and Substitution Therapy Free Live Webinar Series
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Customer Experience and Administration Team
    • Don't miss out! TELUS bonus offer ends September 30, 2019

    • Protect your vehicle and home with the right insurance coverage

    • DDD Notice No. 19133 posted September 20, 2019 ODB Formulary – Edition No. 43, Summary of Changes – September 2019 Summary of Product Changes

    • Gripe Water - Information Update
    • Abbott brand Calcilo XD Powder recalled due to rancidity and off-colour

  • News for the week of September 17, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • September 17, 2019 is declared the first World Patient Safety Day
    • Your fall issue of Ontario Pharmacist and Ontario Pharmacy Technician magazines are here!

    • Injections and Immunizations Program
    • How-To: Ontario's Pharmaceutical Opinion Program
    • Identifying Drug Interactions

    • Ask the Practice Support Network
    • A new focus on students: an engagement strategy
    • Take the 2019-20 OPA membership survey

    • Professional liability coverage - practising in another province

    • Pfizer Canada supply update on PrZINECARD®

    • DDD Notice No. 19130 posted September 13, 2019 Notice from the Executive Officer
    • DDD Notice No. 19127 posted September 12, 2019 Notice from the Executive Officer: Funding Flash Glucose Monitoring System Through the Ontario Drug Benefit Program

    • Gabapentin or Pregabalin with Opioids - Information Update
    • Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; some products being recalled
    • Needle-free dermal filler devices - Information Update

  • News for the week of September 10, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • FluMist Quadrivalent not available this year
    • International Federation on Ageing unites groups to improve vaccination rates
    • Innovative Medicines Canada announces changes to Code of Ethical Practices
    • Political parties gear up for federal election

    • FREE! An Introduction to Caring for Trans Patients in the Pharmacy
    • Implementing Smoking Cessation Services in the Pharmacy
    • Injections and Immunizations Program

    • Ask the Customer Experience and Administration Team
    • Travel discounts as an associate member of CPhA

    • Why buy life insurance?

    • Drug Shortage / Supply Health System Alert: multiple cancer drugs

    • Notice No. 19125 posted September 10, 2019 Prescription Forgery Alert

  • News for the week of September 3, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Justin J. Bates begins new tenure at OPA as new CEO
    • Materials to help in the fight against the opioid crisis

    • OPA Pharmacy Technician Bundle
    • OPA Clinical Bundle
    • OPA Operational Bundle

    • Are you taking advantage of your membership benefits?

    • Overage dependent coverage

    • Health Product InfoWatch - Safety Updates: Cymbalta, Istodax

  • News for the week of August 27, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Draft regulations for expanded scope of practice now open for public consultation
    • Diabetes resources available from the Diabetes Pharmacists Network at the University of Toronto Banting & Best Diabetes Centre

    • The Master Plan for Diabetes Continuing Education Program
    • Medical Devices Training for Pharmacy Technicians
    • Rational Prescribing: Re-thinking Medications

    • New OPA Benefit: The Manulife All-In Banking™ Package Is Here!
    • Ask the Customer Experience and Administration Team

    • Professional Liability Insurance Claims Reporting

    • DDD Notice No. 19123 Posted August 23, 2019 ODB Formulary – Edition No. 43, Summary of Changes – August 2019 Summary of Product Changes

  • News for the week of August 20, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Tell us your thoughts on draft regulations for expanded scope of practice
    • ICYMI: TELUS Health changes to Pharmacy Manual

    • Paid Consultations - Opportunities and Timesavers
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • Identifying Drug Interactions

    • Manulife All-in-Banking now available to OPA members with exclusive opportunities
    • Ask the Practice Support Network
    • Dell Canada back-to-school Member Purchase Plan deals!
    • Are you taking advantage of your OPA membership?

    • OPA Pharmacy (Store) Insurance

    • Drug Shortage / Supply Health System Alert: Pfizer Leucovorin 50ml

Back to top